These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 20059602

  • 1. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
    Dugar M, Cox S, Limaye V, Blumbergs P, Roberts-Thomson PJ.
    Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
    [Abstract] [Full Text] [Related]

  • 2. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
    Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP, Vittecoq O, Noel D, Mouthon L, Menard JF, Jouen F.
    Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
    [Abstract] [Full Text] [Related]

  • 3. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
    Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B, Nunes H, Maisonobe T, Olsson NO, Adoue D, Arlet P, Sibilia J, Guiguet M, Lauque D, Amoura Z, Hachulla E, Hamidou M, Benveniste O.
    Autoimmun Rev; 2012 Dec; 12(2):210-7. PubMed ID: 22771754
    [Abstract] [Full Text] [Related]

  • 4. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.
    Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF, Levesque H, Jouen F.
    Semin Arthritis Rheum; 2012 Jun; 41(6):890-9. PubMed ID: 22078416
    [Abstract] [Full Text] [Related]

  • 5. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
    Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV.
    Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
    [Abstract] [Full Text] [Related]

  • 6. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies.
    Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, Usui T, Tanaka M, Nagai S, Umehara H, Mimori T.
    Autoimmunity; 2006 May; 39(3):233-41. PubMed ID: 16769657
    [Abstract] [Full Text] [Related]

  • 7. Clinical significance of anti-histidyl-tRNA synthetase (Jo1) autoantibodies.
    Gomard-Mennesson E, Fabien N, Cordier JF, Ninet J, Tebib J, Rousset H.
    Ann N Y Acad Sci; 2007 Aug; 1109():414-20. PubMed ID: 17785330
    [Abstract] [Full Text] [Related]

  • 8. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.
    Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, Kodera M, Muroi E, Fujikawa K, Seishima M, Yamada H, Yamada R, Sato S, Takehara K, Kuwana M.
    PLoS One; 2013 Aug; 8(4):e60442. PubMed ID: 23573256
    [Abstract] [Full Text] [Related]

  • 9. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes.
    Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, Walport MJ.
    Q J Med; 1990 Oct; 77(282):1019-38. PubMed ID: 2267280
    [Abstract] [Full Text] [Related]

  • 10. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome.
    Lega JC, Fabien N, Reynaud Q, Durieu I, Durupt S, Dutertre M, Cordier JF, Cottin V.
    Autoimmun Rev; 2014 Sep; 13(9):883-91. PubMed ID: 24704867
    [Abstract] [Full Text] [Related]

  • 11. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P, Dwivedi S, Misra R.
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [Abstract] [Full Text] [Related]

  • 12. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
    Hozumi H, Fujisawa T, Nakashima R, Johkoh T, Sumikawa H, Murakami A, Enomoto N, Inui N, Nakamura Y, Hosono Y, Imura Y, Mimori T, Suda T.
    Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
    [Abstract] [Full Text] [Related]

  • 13. Spectrum and clinical significance of autoantibodies against transfer RNA.
    Ohosone Y, Ishida M, Takahashi Y, Matsumura M, Hirakata M, Kawahara Y, Nishikawa T, Mimori T.
    Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095
    [Abstract] [Full Text] [Related]

  • 14. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase).
    Targoff IN, Arnett FC.
    Am J Med; 1990 Mar; 88(3):241-51. PubMed ID: 2178410
    [Abstract] [Full Text] [Related]

  • 15. Unusually high frequency of autoantibodies to PL-7 associated with milder muscle disease in Japanese patients with polymyositis/dermatomyositis.
    Yamasaki Y, Yamada H, Nozaki T, Akaogi J, Nichols C, Lyons R, Loy AC, Chan EK, Reeves WH, Satoh M.
    Arthritis Rheum; 2006 Jun; 54(6):2004-9. PubMed ID: 16732549
    [Abstract] [Full Text] [Related]

  • 16. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [Abstract] [Full Text] [Related]

  • 17. Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52.
    Yamasaki Y, Satoh M, Mizushima M, Okazaki T, Nagafuchi H, Ooka S, Shibata T, Nakano H, Ogawa H, Azuma K, Maeda A, Tonooka K, Ito H, Takakuwa Y, Inoue M, Mitomi H, Kiyokawa T, Tsuchida K, Matsushita H, Mikage H, Murakami Y, Chan JY, Ozaki S, Yamada H.
    Mod Rheumatol; 2016 Jun; 26(3):403-9. PubMed ID: 26344678
    [Abstract] [Full Text] [Related]

  • 18. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies.
    Sato S, Kuwana M, Hirakata M.
    Rheumatology (Oxford); 2007 May; 46(5):842-5. PubMed ID: 17255133
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study.
    Hozumi H, Enomoto N, Kono M, Fujisawa T, Inui N, Nakamura Y, Sumikawa H, Johkoh T, Nakashima R, Imura Y, Mimori T, Suda T.
    PLoS One; 2015 May; 10(3):e0120313. PubMed ID: 25789468
    [Abstract] [Full Text] [Related]

  • 20. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q.
    BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.